MFDS
- Status: likely_approved
🇰🇷 Onoact in South Korea
Onoact (LANDIOLOL) regulatory status in South Korea.
Marketing authorisation
Onoact in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Onoact approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Onoact in South Korea?
Aop Hlth Us is the originator. The local marketing authorisation holder may differ — check the official source linked above.